Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuropsychiatric Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07600658
What this trial is testing

A Phase I/II, First-In-Human Trial to Evaluate the Safety, Tolerability, and Pharmacokinetic Activity to Prevent or Treat Neuropsychiatric Symptoms in Pediatric Subjects With Timothy Syndrome

Who this might be right for
CACNA1C
Stanford University 5
Post-approval studies (Phase 4)UnknownNCT03348618
What this trial is testing

Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)

Who this might be right for
Pediatric Acute-Onset Neuropsychiatric SyndromePediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections
IMMUNOe Research Centers 21
Not applicableEnded earlyNCT00001260
What this trial is testing

Brain Tissue Collection for Neuropathological Studies

Who this might be right for
Bipolar DisorderDepressionAnxiety Disorders+3 more
National Institute of Mental Health (NIMH) 2,161
Not applicableLooking for participantsNCT06811935
What this trial is testing

PEDI Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcus Study

Who this might be right for
PANSPANDAS
University of Wisconsin, Madison 30
Not applicableStudy completedNCT01034800
What this trial is testing

The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215

Who this might be right for
HIV Infections
National Institute on Drug Abuse (NIDA)
Not applicableEnrolling By InvitationNCT07256795
What this trial is testing

Blood-Brain Barrier Integrity and Immune Dynamics in Neuropsychiatric Sequelae of Post-SARS-CoV-2 Onset ME/CFS Versus Pre-Pandemic ME/CFS Patients

Who this might be right for
Chronic Fatigue Syndrome
Johns Hopkins University 200
Early research (Phase 1)Looking for participantsNCT03705715
What this trial is testing

Identifying Correlates of Brain Microglial Activation in Neuropsychiatric Syndromes: a Dimensional Approach

Who this might be right for
Neuropsychiatric Syndromes
The University of Texas Health Science Center, Houston 200
Not applicableStudy completedNCT05056415
What this trial is testing

Effect and Cost-effectiveness of the Everyday Life Rehabilitation Intervention

Who this might be right for
Psychiatric or Mood Diseases or ConditionsNeuropsychiatric SyndromePsychosis+2 more
Umeå University 161
Not applicableEnded earlyNCT03507218
What this trial is testing

Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS)

Who this might be right for
Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)
National Institute of Mental Health (NIMH) 9
Not applicableLooking for participantsNCT05566392
What this trial is testing

Longterm Influence of Pediatric Long COVID Syndrome

Who this might be right for
COVID-19-Associated EncephalitisLong COVID
National Taiwan University Hospital 500
Not applicableStudy completedNCT02316145
What this trial is testing

Internet-based Coaching for Young Adults With Neuropsychiatric Disorders

Who this might be right for
Attention Deficit Hyperactivity DisorderAutism Spectrum DisorderTourette's Disorder
Vardalinstitutet The Swedish Institute for Health Sciences 12
Not applicableStudy completedNCT03736577
What this trial is testing

Psychotropic Drug Use in the Elderly Living in Nursing Homes and the Influence of a Structured Drug Review

Who this might be right for
Cognitive SymptomDepressionAnxiety+5 more
Ostfold Hospital Trust 224
Not applicableStudy completedNCT00001547
What this trial is testing

Neuropsychiatric Effects of Interferon-Alpha and Ribavirin

Who this might be right for
Mental Disorder
National Institute of Mental Health (NIMH) 150
Not applicableStudy completedNCT00476671
What this trial is testing

Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 100
Post-approval studies (Phase 4)Looking for participantsNCT07678268
What this trial is testing

Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Compared With Darunavir/Cobicistat Plus Tenofovir Alafenamide/Emtricitabine in Virologically Suppressed People Living With HIV at 24 and 48 Weeks of Follow-up

Who this might be right for
HIV InfectionAntiretroviral TherapyLentivirus Infections
Instituto Mexicano del Seguro Social 78
Not applicableStudy completedNCT04382716
What this trial is testing

Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS): Clinical Characterization and Prospective Course

Who this might be right for
PANSPANDAS
University of Minnesota 22
Early research (Phase 1)Study completedNCT02895906
What this trial is testing

Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric Conditions

Who this might be right for
22q11.2 Deletion Syndrome
Aevi Genomic Medicine, LLC, a Cerecor company 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07714213
What this trial is testing

Post-acute Infectious Syndrome - Aripiprazole Symptom Evaluation (PAIS-AriSE)

Who this might be right for
Post-acute Infectious Syndrome (PAIS)Post-COVID-19 Condition (PCC or Long COVID)
Christiana Franke 138
Large-scale testing (Phase 3)Study completedNCT04508530
What this trial is testing

Phase III Study To Compare The Effect of Panzyga Versus Placebo in Patients With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS/PANDAS)

Who this might be right for
Pediatric Acute-Onset Neuropsychiatric Syndrome
Octapharma 71
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07812181
What this trial is testing

An Open-Label Phase II Feasibility Study for the Use of Ublituximab in Adults With Down Syndrome Regression Disorder

Who this might be right for
Down Syndrome Regression Disorder (DSRD)Down Syndrome (Trisomy 21)Neuroinflammatory / Neuropsychiatric Disorder
Jonathan Santoro 20
Next Page